keyword
https://read.qxmd.com/read/34769283/long-chain-and-very-long-chain-ceramides-mediate-doxorubicin-induced-toxicity-and-fibrosis
#41
JOURNAL ARTICLE
Tom Kretzschmar, Mohamed M Bekhite, Jasmine M F Wu, Daniela Haase, Martin Förster, Tina Müller, Sandor Nietzsche, Martin Westermann, Marcus Franz, Markus H Gräler, P Christian Schulze
Doxorubicin (Dox) is a chemotherapeutic agent with cardiotoxicity associated with profibrotic effects. Dox increases ceramide levels with pro-inflammatory effects, cell death, and fibrosis. The purpose of our study was to identify the underlying ceramide signaling pathways. We aimed to characterize the downstream effects on cell survival, metabolism, and fibrosis. Human fibroblasts (hFSF) were treated with 0.7 µM of Dox or transgenically overexpressed ceramide synthase 2 (FLAG-CerS2). Furthermore, cells were pre-treated with MitoTempo (MT) (2 h, 20 µM) or Fumonisin B1 (FuB) (4 h, 100 µM)...
November 1, 2021: International Journal of Molecular Sciences
https://read.qxmd.com/read/34686591/ceramide-accumulation-induces-mitophagy-and-impairs-%C3%AE-oxidation-in-pink1-deficiency
#42
JOURNAL ARTICLE
Melissa Vos, Marija Dulovic-Mahlow, Frida Mandik, Lisa Frese, Yuliia Kanana, Sokhna Haissatou Diaw, Julia Depperschmidt, Claudia Böhm, Jonas Rohr, Thora Lohnau, Inke R König, Christine Klein
Energy production via the mitochondrial electron transport chain (ETC) and mitophagy are two important processes affected in Parkinson's disease (PD). Interestingly, PINK1, mutations of which cause early-onset PD, plays a key role in both processes, suggesting that these two mechanisms are connected. However, the converging link of both pathways currently remains enigmatic. Recent findings demonstrated that lipid aggregation, along with defective mitochondria, is present in postmortem brains of PD patients...
October 26, 2021: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/34602551/amyloid-beta-peptide-25-35-a%C3%AE-25-35-induces-cytotoxicity-via-multiple-mechanisms-roles-of-the-inhibition-of-glucosylceramide-synthase-by-a%C3%AE-25-35-and-its-protection-by-d609
#43
JOURNAL ARTICLE
Zhihui Tang, Kaisei Motoyoshi, Takuya Honda, Hiroyuki Nakamura, Toshihiko Murayama
Sphingolipids (SLs), such as ceramide, glucosylceramide (GlcCer), and sphingomyelin, play important roles in the normal development/functions of the brain and peripheral tissues. Disruption of SL homeostasis in cells/organelles, specifically up-regulation of ceramide, is involved in multiple diseases including Alzheimer's disease (AD). One of the pathological features of AD is aggregates of amyloid beta (Aβ) peptides, and SLs regulate both the formation/aggregation of Aβ and Aβ-induced cellular responses...
2021: Biological & Pharmaceutical Bulletin
https://read.qxmd.com/read/34563520/metabolism-of-hsan1-and-t2dm-associated-1-deoxy-sphingolipids-inhibits-the-migration-of-fibroblasts
#44
JOURNAL ARTICLE
Gergely Karsai, Regula Steiner, Andres Kaech, Museer A Lone, Arnold von Eckardstein, Thorsten Hornemann
Hereditary sensory neuropathy type 1 (HSAN1) is a rare axonopathy, characterized by a progressive loss of sensation (pain, temperature, and vibration), neuropathic pain and wound healing defects. HSAN1 is caused by several missense mutations in the SPTLC1 and SPTLC2 subunit of the enzyme serine-palmitoyltransferase (SPT) -the key enzyme for the synthesis of sphingolipids. The mutations change the substrate specificity of SPT, which then forms an atypical class of 1-deoxy-sphinglipids (1-deoxySL). Similarly, patients with type 2 diabetes (T2DM) also present with elevated 1-deoxySLs and a comparable clinical phenotype...
September 23, 2021: Journal of Lipid Research
https://read.qxmd.com/read/34443686/integratomics-of-human-dermal-fibroblasts-treated-with-low-molecular-weight-hyaluronic-acid
#45
JOURNAL ARTICLE
Silvia Radrezza, Gilda Aiello, Giovanna Baron, Giancarlo Aldini, Marina Carini, Alfonsina D'Amato
Hyaluronic acid (HA) is a glycosaminoglycan very common in commercial products from pharmaceuticals to cosmetics due to its widespread distribution in humans and its diversified physico-chemical proprieties. Despite its extended use and preliminary evidence showing even also opposite activities to the native form, the precise cellular effects of HA at low-molecular-weight (LWM-HA) are currently unclear. The 'omics sciences currently in development offer a new and combined perspective on the cellular and organismal environment...
August 23, 2021: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/34303789/sphingolipid-imbalance-and-inflammatory-effects-induced-by-uremic-toxins-in-heart-and-kidney-cells-are-reversed-by-dihydroceramide-desaturase-1-inhibition
#46
JOURNAL ARTICLE
Feby Savira, Ruth Magaye, Carmen V Scullino, Bernard L Flynn, Stuart M Pitson, Dovile Anderson, Darren J Creek, Yue Hua, Xin Xiong, Li Huang, Danny Liew, Christopher Reid, David Kaye, Andrew R Kompa, Bing Hui Wang
Non-dialysable protein-bound uremic toxins (PBUTs) contribute to the development of cardiovascular disease (CVD) in chronic kidney disease (CKD) and vice versa. PBUTs have been shown to alter sphingolipid imbalance. Dihydroceramide desaturase 1 (Des1) is an important gatekeeper enzyme which controls the non-reversible conversion of sphingolipids, dihydroceramide, into ceramide. The present study assessed the effect of Des1 inhibition on PBUT-induced cardiac and renal effects in vitro, using a selective Des1 inhibitor (CIN038)...
July 22, 2021: Toxicology Letters
https://read.qxmd.com/read/34277924/dihydrosphingosine-driven-enrichment-of-sphingolipids-attenuates-tgf%C3%AE-induced-collagen-synthesis-in-cardiac-fibroblasts
#47
JOURNAL ARTICLE
Ruth R Magaye, Feby Savira, Xin Xiong, Kevin Huynh, Peter J Meikle, Christopher Reid, Bernard L Flynn, David Kaye, Danny Liew, Bing H Wang
The sphingolipid de novo synthesis pathway, encompassing the sphingolipids, the enzymes and the cell membrane receptors, are being investigated for their role in diseases and as potential therapeutic targets. The intermediate sphingolipids such as dihydrosphingosine (dhSph) and sphingosine (Sph) have not been investigated due to them being thought of as precursors to other more active lipids such as ceramide (Cer) and sphingosine 1 phosphate (S1P). Here we investigated their effects in terms of collagen synthesis in primary rat neonatal cardiac fibroblasts (NCFs)...
August 2021: IJC Heart & Vasculature
https://read.qxmd.com/read/34102611/acid-ceramidase-promotes-senescent-cell-survival
#48
JOURNAL ARTICLE
Rachel Munk, Carlos Anerillas, Martina Rossi, Dimitrios Tsitsipatis, Jennifer L Martindale, Allison B Herman, Jen-Hao Yang, Jackson A Roberts, Vijay R Varma, Poonam R Pandey, Madhav Thambisetty, Myriam Gorospe, Kotb Abdelmohsen
Cellular senescence is linked to chronic age-related diseases including atherosclerosis, diabetes, and neurodegeneration. Compared to proliferating cells, senescent cells express distinct subsets of proteins. In this study, we used cultured human diploid fibroblasts rendered senescent through replicative exhaustion or ionizing radiation to identify proteins differentially expressed during senescence. We identified acid ceramidase (ASAH1), a lysosomal enzyme that cleaves ceramide into sphingosine and fatty acid, as being highly elevated in senescent cells...
June 8, 2021: Aging
https://read.qxmd.com/read/34088014/generation-of-an-induced-pluripotent-stem-cell-line-trndi030-a-from-a-patient-with-farber-disease-carrying-a-homozygous-p-y36c-c-107-a-g-mutation-in-asah1
#49
JOURNAL ARTICLE
Brianna M Brooks, Charles D Yeh, Jeanette Beers, Chengyu Liu, Yu-Shan Cheng, Kirill Gorshkov, Jizhong Zou, Wei Zheng, Catherine Z Chen
Farber disease is an ultra-rare lysosomal storage disease. Mutations in the N-acylsphingosine amidohydrolase (ASAH1) gene, which encodes for the enzyme acid ceramidase (ACDase), cause ceramides to accumulate in the body. A human induced pluripotent stem cell (iPSC) line TRNDi030-A was generated from fibroblasts of a male patient with a homozygous p. Y36C (c.107 A>G) variant in the second exon of the ASAH1 producing the alpha subunit of ACDase. This Farber disease iPSC line is a useful resource to study disease pathophysiology and to develop therapeutics for treatment of patients with Farber disease...
May 2021: Stem Cell Research
https://read.qxmd.com/read/34069977/different-lipid-signature-in-fibroblasts-of-long-chain-fatty-acid-oxidation-disorders
#50
JOURNAL ARTICLE
Khaled I Alatibi, Judith Hagenbuchner, Zeinab Wehbe, Daniela Karall, Michael J Ausserlechner, Jerry Vockley, Ute Spiekerkoetter, Sarah C Grünert, Sara Tucci
Long-chain fatty acid oxidation disorders (lc-FAOD) are a group of diseases affecting the degradation of long-chain fatty acids. In order to investigate the disease specific alterations of the cellular lipidome, we performed undirected lipidomics in fibroblasts from patients with carnitine palmitoyltransferase II, very long-chain acyl-CoA dehydrogenase, and long-chain 3-hydroxyacyl-CoA dehydrogenase. We demonstrate a deep remodeling of mitochondrial cardiolipins. The aberrant phosphatidylcholine/phosphatidylethanolamine ratio and the increased content of plasmalogens and of lysophospholipids support the theory of an inflammatory phenotype in lc-FAOD...
May 18, 2021: Cells
https://read.qxmd.com/read/33938457/suppressing-the-intestinal-farnesoid-x-receptor-sphingomyelin-phosphodiesterase-3-axis-decreases-atherosclerosis
#51
JOURNAL ARTICLE
Qing Wu, Lulu Sun, Xiaomin Hu, Xuemei Wang, Feng Xu, Bo Chen, Xianyi Liang, Jialin Xia, Pengcheng Wang, Daisuke Aibara, Shaofei Zhang, Guangyi Zeng, Chuyu Yun, Yu Yan, Yicheng Zhu, Michael Bustin, Shuyang Zhang, Frank J Gonzalez, Changtao Jiang
Intestinal farnesoid X receptor (FXR) signaling is involved in the development of obesity, fatty liver disease, and type 2 diabetes. However, the role of intestinal FXR in atherosclerosis and its potential as a target for clinical treatment have not been explored. The serum levels of fibroblast growth factor 19 (FGF19), which is encoded by an FXR target gene, were much higher in patients with hypercholesterolemia than in control subjects and were positively related to circulating ceramide levels, indicating a link between intestinal FXR, ceramide metabolism, and atherosclerosis...
May 3, 2021: Journal of Clinical Investigation
https://read.qxmd.com/read/33918064/effects-of-natural-antioxidants-on-phospholipid-and-ceramide-profiles-of-3d-cultured-skin-fibroblasts-exposed-to-uva-or-uvb-radiation
#52
JOURNAL ARTICLE
Agnieszka Gęgotek, Wojciech Łuczaj, Elżbieta Skrzydlewska
Ultraviolet (UV) radiation is one of the primary factors responsible for disturbances in human skin cells phospholipid metabolism. Natural compounds that are commonly used to protect skin, due to their lipophilic or hydrophilic nature, show only a narrow range of cytoprotective activity, which prompts research on their combined application. Therefore, the aim of this study was to examine the effect of ascorbic acid and rutin on the phospholipid and ceramide profiles in UV-irradiated fibroblasts cultured in a three-dimensional system that approximates the culture conditions to the dermis...
April 8, 2021: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/33914445/sphingosine-1-phosphate-contributes-to-tlr9-induced-tnf-%C3%AE-release-in-lung-tumor-cells
#53
JOURNAL ARTICLE
Michela Terlizzi, Chiara Colarusso, Giusy Ferraro, Maria Chiara Monti, Ida Cerqua, Fiorentina Roviezzo, Aldo Pinto, Rosalinda Sorrentino
BACKGROUND/AIMS: Sphingosine-1-phosphate (S1P) is a membrane-derived bioactive phospholipid involved in many lung physiological and pathological processes. Higher levels of S1P have been registered in a broad range of respiratory diseases, including inflammatory disorders and cancer. The aim of our study was to understand the role of S1P in healthy versus tumor cells after Toll-Like Receptors (TLRs) activation, well-known modulators of sphingolipid metabolism. METHODS: Lung adenocarcinoma cells and non-pathological human fibroblasts were stimulated with unmethylated Cytosine phosphate Guanosine (CpG), the TLR9 ligand, and S1P-dependent TNF-α release was evaluated by means of ELISA...
April 30, 2021: Cellular Physiology and Biochemistry
https://read.qxmd.com/read/33832803/the-interplay-between-glucocerebrosidase-%C3%AE-synuclein-and-lipids-in-human-models-of-parkinson-s-disease
#54
JOURNAL ARTICLE
Sonia Sanz Muñoz, Daniel Petersen, Frederik Ravnkilde Marlet, Ebru Kücükköse, Céline Galvagnion
Mutations in the gene GBA, encoding glucocerebrosidase (GCase), are the highest genetic risk factor for Parkinson's disease (PD). GCase is a lysosomal glycoprotein responsible for the hydrolysis of glucosylceramide into glucose and ceramide. Mutations in GBA cause a decrease in GCase activity, stability and protein levels which in turn lead to the accumulation of GCase lipid substrates as well as α-synuclein (αS) in vitro and in vivo. αS is the main constituent of Lewy bodies found in the brain of PD patients and an increase in its levels was found to be associated with a decrease in GCase activity/protein levels in vitro and in vivo...
December 25, 2020: Biophysical Chemistry
https://read.qxmd.com/read/33727076/regulation-of-cell-growth-survival-and-migration-by-ceramide-1-phosphate-implications-in-lung-cancer-progression-and-inflammation
#55
JOURNAL ARTICLE
Ana Gomez-Larrauri, Alberto Ouro, Miguel Trueba, Antonio Gomez-Muñoz
Ceramide 1-phosphate (C1P) is a bioactive sphingolipid that is implicated in the regulation of vital cellular functions and plays key roles in a number of inflammation-associated pathologies. C1P was first described as mitogenic for fibroblasts and macrophages and was later found to promote cell survival in different cell types. The mechanisms involved in the mitogenic actions of C1P include activation of MEK/ERK1-2, PI3K/Akt/mTOR, or PKC-α, whereas promotion of cell survival required a substantial reduction of ceramide levels through inhibition of serine palmitoyl transferase or sphingomyelinase activities...
March 13, 2021: Cellular Signalling
https://read.qxmd.com/read/33665756/acid-sphingomyelinase-and-acid-%C3%AE-glucosidase-1-exert-opposite-effects-on-interleukin-1%C3%AE-induced-interleukin-6-production-in-rheumatoid-arthritis-fibroblast-like-synoviocytes
#56
JOURNAL ARTICLE
Mengmeng Zhao, Maowei Yang, Xu Li, Linxin Hou, Xudong Liu, Weiguo Xiao
Acid sphingomyelinase (ASM) and acid β-glucosidase 1 (GBA1) catalyze ceramide formation through different routes, and both are involved in rheumatoid arthritis (RA) pathogenesis as well as IL-6 production. However, whether ASM and GBA1 regulate IL-6 production in RA remains unknown. Serum ASM, GBA1, and ceramide levels were measured in RA patients and healthy controls by enzyme-linked immunosorbent assay, and their correlations with clinical indicators of patients were evaluated. Pharmacologic inhibitors or small hairpin RNAs of ASM and GBA1 were employed to explore the roles of ASM and GBA1 in IL-6 production, cell behavior, and MAPK signaling in fibroblast-like synoviocytes from RA patients (RAFLS)...
August 2021: Inflammation
https://read.qxmd.com/read/33509590/repression-of-sphingosine-kinase-sk-interacting-protein-skip-in-acute-myeloid-leukemia-diminishes-sk-activity-and-its-re-expression-restores-sk-function
#57
JOURNAL ARTICLE
Essam A Ghazaly, Farideh Miraki-Moud, Paul Smith, Chathunissa Gnanaranjan, Lola Koniali, Adedayo Oke, Marwa H Saied, Robert Petty, Janet Matthews, Randal Stronge, Simon P Joel, Bryan D Young, John Gribben, David C Taussig
Previous studies have shown that sphingosine kinase interacting protein (SKIP) inhibits sphingosine kinase (SK) function in fibroblasts. SK phosphorylates sphingosine producing the potent signaling molecule sphingosine-1-phosphate (S1P). SKIP gene (SPHKAP) expression is silenced by hypermethylation of its promoter in acute myeloid leukemia (AML). However, why SKIP activity is silenced in primary AML cells is unclear. Here, we investigated the consequences of SKIP down-regulation in AML primary cells and the effects of SKIP re-expression in leukemic cell lines...
April 17, 2020: Journal of Biological Chemistry
https://read.qxmd.com/read/32956750/the-adaptation-of-lipid-profile-of-human-fibroblasts-to-alginate-2d-films-and-3d-printed-scaffolds
#58
JOURNAL ARTICLE
Ilaria Zanotti, Silvia Marando, Giulia Remaggi, Carlo Bergonzi, Franco Bernini, Ruggero Bettini, Lisa Elviri
BACKGROUND: The investigation of the interactions between cells and active materials is pivotal in the emerging 3D printing-biomaterial application fields. Here, lipidomics has been used to explore the early impact of alginate (ALG) hydrogel architecture (2D films or 3D printed scaffolds) and the type of gelling agent (CaCl2 or FeCl3 ) on the lipid profile of human fibroblasts. METHODS: 2D and 3D ALG scaffolds were prepared and characterized in terms of water content, swelling, mechanical resistance and morphology before human fibroblast seeding (8 days)...
September 18, 2020: Biochimica et Biophysica Acta. General Subjects
https://read.qxmd.com/read/32835606/1-deoxysphingolipids-cause-autophagosome-and-lysosome-accumulation-and-trigger-nlrp3-inflammasome-activation
#59
JOURNAL ARTICLE
Mario A Lauterbach, Victor Saavedra, Matthew S J Mangan, Anke Penno, Christoph Thiele, Eicke Latz, Lars Kuerschner
1-Deoxysphingolipids (deoxySLs) are atypical sphingolipids of clinical relevance as they are elevated in plasma of patients suffering from hereditary sensory and autonomic neuropathy (HSAN1) or type 2 diabetes. Their neurotoxicity is described best but they inflict damage to various cell types by an uncertain pathomechanism. Using mouse embryonic fibroblasts and an alkyne analog of 1-deoxysphinganine (doxSA), the metabolic precursor of all deoxySLs, we here study the impact of deoxySLs on macroautophagy/autophagy, the regulated degradation of dysfunctional or expendable cellular components...
August 24, 2020: Autophagy
https://read.qxmd.com/read/32682944/sphingosine-1-phosphate-lyase-sgpl1-deficiency-is-associated-with-mitochondrial-dysfunction
#60
JOURNAL ARTICLE
A Maharaj, J Williams, T Bradshaw, T Güran, D Braslavsky, J Casas, L F Chan, L A Metherell, R Prasad
Deficiency in Sphingosine-1-phosphate lyase (S1P lyase) is associated with a multi-systemic disorder incorporating primary adrenal insufficiency (PAI), steroid resistant nephrotic syndrome and neurological dysfunction. Accumulation of sphingolipid intermediates, as seen with loss of function mutations in SGPL1, has been implicated in mitochondrial dysregulation, including alterations in mitochondrial membrane potentials and initiation of mitochondrial apoptosis. For the first time, we investigate the impact of S1P lyase deficiency on mitochondrial morphology and function using patient-derived human dermal fibroblasts and CRISPR engineered SGPL1-knockout HeLa cells...
September 2020: Journal of Steroid Biochemistry and Molecular Biology
keyword
keyword
164176
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.